The application of nanotechnology to medicine, usually termed nanomedicine, has given a
crucial impulse to the design of various drug-loaded nanocarriers driven by the aim to …

Microtubule targeting agents (MTAs) have attracted extensive attention for cancer treatment.
However, their clinical efficacies are limited by intolerable toxicities, inadequate efficacy and …

Chemotherapy continues to be the most commonly applied strategy for cancer. Despite the
impressive clinical success obtained with several drugs, increasing numbers of (multi) drug …

Conventional chemotherapy and radiotherapy are nonselective and nonspecific for cell
killing, causing serious side effects and threatening the lives of patients. It is of great …

Abnormal tumor microenvironment (TME) facilitates tumor proliferation and metastasis and
establishes physiological barriers for effective transport of therapeutics inside the tumor …

As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has
been compromised, and in spite of introducing various kinds of anticancer drugs, cancer …

The biocompatible protein nanocarrier with homogeneous particle size is a promising
candidate material for the delivery of targeted drugs to tumors. Doxorubicin (DOX) is a …

Herein, a one‐step solvothermal strategy to synthesize amphiphilic, highly fluorescent
graphene quantum dots (GQDs) as nucleus‐targeted fluorescence probes is reported. The …

Viral nanoparticles (VNPs) comprise a variety of mammalian viruses, plant viruses, and
bacteriophages, that have been adopted as building blocks and supra-molecular templates …

An ideal brain-targeted nanocarrier must be sufficiently potent to penetrate the blood–brain
barrier (BBB) and sufficiently competent to target the cells of interest with adequate …